Flagship Pioneering has announced that ProFound Therapeutics and Quotient Therapeutics [...]
Cereno Scientific, a biotechnology company pioneering treatments for rare cardiovascular [...]
Qureight’s deep-learning biomarkers confirm representativeness of Insilico’s Phase 2a IPF [...]